Filing Details
- Accession Number:
- 0001209191-15-071434
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-18 17:15:05
- Reporting Period:
- 2015-09-18
- Filing Date:
- 2015-09-18
- Accepted Time:
- 2015-09-18 17:15:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1269021 | Portola Pharmaceuticals Inc | PTLA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1192591 | J Charles Homcy | C/O Portola Pharmaceuticals, Inc. 270 East Grand Ave. South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-09-18 | 20,067 | $3.30 | 20,067 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-09-18 | 20,067 | $55.00 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-09-18 | 20,000 | $5.00 | 20,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-09-18 | 20,000 | $57.50 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-09-18 | 20,067 | $0.00 | 20,067 | $3.30 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-09-18 | 20,000 | $0.00 | 20,000 | $5.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2006-09-06 | 2016-09-06 | No | 4 | M | Direct |
0 | 2007-09-20 | 2017-09-20 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2015.
- These shares were sold in a single transaction at a price of $55.00.
- These shares were sold in a single transaction at a price of $57.5000.